873306-31-1 Usage
Structure
2-(diMethylaMino)-N-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetaMide, which describes the arrangement of atoms and functional groups in the molecule.
Brightness
BODIPY-FL-AM is known for its high brightness, which allows it to produce strong and easily detectable fluorescence signals.
Photostability
BODIPY-FL-AM exhibits high photostability, meaning it can resist photobleaching and maintain its fluorescence properties over time.
Emission wavelength
BODIPY-FL-AM has an emission wavelength in the visible region of the spectrum, which allows it to be visualized using standard fluorescence microscopy techniques.
Biological applications
BODIPY-FL-AM is used in a variety of biological applications, including labeling and imaging of cellular compartments and organelles in live cells.
Research areas
BODIPY-FL-AM is utilized in various research areas, such as cell biology, molecular imaging, and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 873306-31-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,3,0 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 873306-31:
(8*8)+(7*7)+(6*3)+(5*3)+(4*0)+(3*6)+(2*3)+(1*1)=171
171 % 10 = 1
So 873306-31-1 is a valid CAS Registry Number.
873306-31-1Relevant academic research and scientific papers
FURANOPYRIMIDINES
-
Page/Page column 54, (2010/02/15)
The present invention relates to furanopyrimidine compounds having the general Formula (I) and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula (I), methods of treating various diseases and conditions in a mammal, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma and thymoma, comprising administering to the mammal a therapeutically effective amount of a compound of Formula (I). The invention also relates to methods of manufacturing medicaments, which comprise one or more compounds of Formula (I).
